We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEC icon
9926
PUT
Orion
OEC
$358M
$390K ﹤0.01%
+21,400
New +$383K
TYD icon
9927
PUT
Direxion Daily 7-10 Year Treasury Bull 3X ETF
TYD
$30.4M
$390K ﹤0.01%
7,400
-3,100
-30% -$171K
VRS
9928
PUT
DELISTED
Verso Corporation
VRS
$390K ﹤0.01%
18,800
-6,700
-26% -$129K
BSN
9929
DELISTED
Broadstone Acquisition Corp.
BSN
$390K ﹤0.01%
+39,240
New +$388K
BWFG icon
9930
Bankwell Financial Group
BWFG
$531M
$389K ﹤0.01%
+13,213
New +$385K
GALT icon
9931
Galectin Therapeutics
GALT
$405M
$389K ﹤0.01%
100,320
-35,190
-26% -$119K
GMAB icon
9932
CALL
Genmab
GMAB
$20.4B
$389K ﹤0.01%
8,900
-56,500
-86% -$2.54M
AHT
9933
Ashford Hospitality Trust
AHT
$21M
$388K ﹤0.01%
2,634
-31,539
-92% -$5.34M
BIS icon
9934
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.87M
$388K ﹤0.01%
10,753
-6,555
-38% -$229K
GNPX icon
9935
PUT
Genprex
GNPX
$3.01M
$388K ﹤0.01%
3
MRKR icon
9936
Marker Therapeutics
MRKR
$22.8M
$388K ﹤0.01%
22,938
+18,176
+382% +$372K
REFR icon
9937
Research Frontiers
REFR
$16.1M
$388K ﹤0.01%
151,491
+50,200
+50% +$116K
SCU
9938
CALL
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$388K ﹤0.01%
13,900
-2,100
-13% -$54.5K
BLU
9939
DELISTED
BELLUS Health Inc.
BLU
$388K ﹤0.01%
+63,130
New +$239K
IRWD icon
9940
PUT
Ironwood Pharmaceuticals
IRWD
$682M
$387K ﹤0.01%
29,600
-7,700
-21% -$99.5K
SLP icon
9941
PUT
Simulations Plus
SLP
$372M
$387K ﹤0.01%
9,800
-900
-8% -$41.1K
EMBJ
9942
Embraer S.A. ADS
EMBJ
$12.9B
$386K ﹤0.01%
22,733
-407,300
-95% -$6.32M
GNL icon
9943
Global Net Lease
GNL
$2.12B
$386K ﹤0.01%
+24,124
New +$424K
MLI icon
9944
PUT
Mueller Industries
MLI
$13.9B
$386K ﹤0.01%
37,600
TMFS icon
9945
Motley Fool Small-Cap Growth ETF
TMFS
$58.7M
$386K ﹤0.01%
+9,860
New +$392K
VECO icon
9946
PUT
Veeco
VECO
$2.71B
$386K ﹤0.01%
17,400
+5,500
+46% +$123K
TRVN
9947
CALL
DELISTED
Trevena, Inc.
TRVN
$386K ﹤0.01%
502
-46
-8% -$39K
GTPAU
9948
DELISTED
Gores Technology Partners, Inc. Units
GTPAU
$386K ﹤0.01%
38,632
CVSA
9949
Covista Inc
CVSA
$4.58B
$385K ﹤0.01%
10,192
-195,571
-95% -$7.26M
HGV icon
9950
PUT
Hilton Grand Vacations
HGV
$3.41B
$385K ﹤0.01%
8,100
-9,400
-54% -$398K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.